Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
Saved in:
| Date: | 2013 |
|---|---|
| Main Authors: | O. D. Ryabtseva, Yu. Lukianova, Yu. A. Shmurakov, L. Z. Polishchuk, S. V. Antipova |
| Format: | Article |
| Language: | English |
| Published: |
2013
|
| Series: | Experimental Oncology |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000111250 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Individual prognosis of serous ovarian cancer survival patients based on adhesion and proliferation of tumor cells
by: O. D. Ryabtseva, et al.
Published: (2014)
by: O. D. Ryabtseva, et al.
Published: (2014)
Biological features of serous ovarian cancer with regard to the r53 expression and its modulators
by: I. P. Nesina, et al.
Published: (2015)
by: I. P. Nesina, et al.
Published: (2015)
Survivin expression in ovarian cancer
by: Liguang, Z., et al.
Published: (2007)
by: Liguang, Z., et al.
Published: (2007)
Biomolecular markers as factors of prognosis of stage 3-4 ovarian cancer
by: A. A. Mikhanovskij, et al.
Published: (2016)
by: A. A. Mikhanovskij, et al.
Published: (2016)
Ovarian cancer: family cancer syndrome and clinical significance of testing of the mutations in BRCA1 and BRCA2?genes
by: O. V. Paliichuk, et al.
Published: (2016)
by: O. V. Paliichuk, et al.
Published: (2016)
The role of intercellular adhesion molecule-1 in head and neck cancer
by: Georgolios, A., et al.
Published: (2006)
by: Georgolios, A., et al.
Published: (2006)
Molecular-biological tumor markers expression level evaluation in patients with stage III-IV ovarian cancer of with the aim of relapse and metastasis risk prognosis
by: A. A. Mikhanovskij, et al.
Published: (2017)
by: A. A. Mikhanovskij, et al.
Published: (2017)
Expression OF p53, p21WAF1/CIP1 , p16INK4A and Ki-67 proteins in serous ovarian tumors
by: Buchynska, L.G., et al.
Published: (2007)
by: Buchynska, L.G., et al.
Published: (2007)
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: S. Chekhun, et al.
Published: (2013)
by: S. Chekhun, et al.
Published: (2013)
The value of iodide symporter for prognosis of breast cancer of different molecular subtypes
by: Yu. Lukianova, et al.
Published: (2017)
by: Yu. Lukianova, et al.
Published: (2017)
The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
by: V. F. Chekhun, et al.
Published: (2017)
by: V. F. Chekhun, et al.
Published: (2017)
Immunohistochemical factors of endometrial cancer prognosis
by: A. A. Mikhanovskij, et al.
Published: (2018)
by: A. A. Mikhanovskij, et al.
Published: (2018)
Factors of prognosis in rectal cancer patients
by: B. B. Tataryn, et al.
Published: (2019)
by: B. B. Tataryn, et al.
Published: (2019)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: S. V. Chekhun, et al.
Published: (2014)
by: S. V. Chekhun, et al.
Published: (2014)
Clinical significance of hormonal receptor status of malignant ovarian tumors
by: I. G. Tkalia, et al.
Published: (2014)
by: I. G. Tkalia, et al.
Published: (2014)
Clinical significance of hormonal receptor status of malignant ovarian tumors
by: Tkalia, I.G., et al.
Published: (2014)
by: Tkalia, I.G., et al.
Published: (2014)
Contemporary views on the etiology and pathogenesis of ovarian cancer
by: T. V. Bazarinskaja
Published: (2018)
by: T. V. Bazarinskaja
Published: (2018)
Features of hepcidin expression in patients with breast cancer
by: Yu. Lukianova, et al.
Published: (2015)
by: Yu. Lukianova, et al.
Published: (2015)
Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018)
by: S. M. Hrybach, et al.
Published: (2018)
Statistical analysis of diagnosis and treatment of serous otitis media in children
by: H. I. Hariuk, et al.
Published: (2017)
by: H. I. Hariuk, et al.
Published: (2017)
Molecular-biological features of ovarian cancer patients with aggregation of cancer in pedigrees
by: I. P. Nesina, et al.
Published: (2017)
by: I. P. Nesina, et al.
Published: (2017)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: Shepil, O.V., et al.
Published: (2014)
by: Shepil, O.V., et al.
Published: (2014)
Molecular profile of gastric cancer as a basis of individualized treatment and prognosis of disease outcome
by: Demash, D.V., et al.
Published: (2011)
by: Demash, D.V., et al.
Published: (2011)
Experience of diagnostic laparoscopy use in patients with advanced ovarian cancer
by: O. A. Mikhanovskyi, et al.
Published: (2019)
by: O. A. Mikhanovskyi, et al.
Published: (2019)
Effects of alvocidib and carboplatin on ovarian cancer cells in vitro
by: Baumann, K.H., et al.
Published: (2013)
by: Baumann, K.H., et al.
Published: (2013)
Current recommendations for the diagnosis and treatment of epithelial ovarian cancer
by: V. S. Svintsitskyi, et al.
Published: (2019)
by: V. S. Svintsitskyi, et al.
Published: (2019)
Effects of alvocidib and carboplatin on ovarian cancer cells in vitro
by: K. H. Baumann, et al.
Published: (2013)
by: K. H. Baumann, et al.
Published: (2013)
Significance of angiogenic growth factors in prognosis of fetal growth retardation syndrome development
by: M. O. Shcherbyna, et al.
Published: (2014)
by: M. O. Shcherbyna, et al.
Published: (2014)
Ways of improving the results of treatment of advanced forms of ovarian cancer
by: A. A. Mikhanovskij, et al.
Published: (2015)
by: A. A. Mikhanovskij, et al.
Published: (2015)
Manifestations of oxidative stress and molecular damages in ovarian cancer tissue
by: H. I. Falfushynska, et al.
Published: (2015)
by: H. I. Falfushynska, et al.
Published: (2015)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: O. V. Shepil, et al.
Published: (2014)
by: O. V. Shepil, et al.
Published: (2014)
Breast cancer: epidemiology, risk factors, pathogenesis, diagnosis, prognosis
by: S. E. Ragimzade
Published: (2017)
by: S. E. Ragimzade
Published: (2017)
Quality of life of patients with ovarian cancer after cytoreductive surgery and chemotherapy
by: A. I. Rybin, et al.
Published: (2018)
by: A. I. Rybin, et al.
Published: (2018)
Evaluation of serum adenosine deaminase and its isoenzymes in patients with ovarian cancer
by: A. Asadi, et al.
Published: (2018)
by: A. Asadi, et al.
Published: (2018)
Analysis of the efficacy of combination treatment of ovarian cancer patients with neoadjuvant chemotherapy
by: A. A. Mikhanovskij, et al.
Published: (2014)
by: A. A. Mikhanovskij, et al.
Published: (2014)
Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
by: Kirkilevsky, S.I., et al.
Published: (2023)
by: Kirkilevsky, S.I., et al.
Published: (2023)
Quantitative analysis of SLC34A2 expression in different types of ovarian tumors
by: Shyian, M., et al.
Published: (2011)
by: Shyian, M., et al.
Published: (2011)
The possibility of cytological diagnostics in preoperative prognosis of radioiodine resistance of papillary thyroid cancer
by: H. V. Zelinska
Published: (2018)
by: H. V. Zelinska
Published: (2018)
Topoisomerase IIα determins the prognosis and response to chemotherapy in patients with operable breast cancer
by: D. E. Ryspaeva, et al.
Published: (2017)
by: D. E. Ryspaeva, et al.
Published: (2017)
Women ovarian autoimmunity
by: Yu. Voznesenska, et al.
Published: (2011)
by: Yu. Voznesenska, et al.
Published: (2011)
Similar Items
-
Individual prognosis of serous ovarian cancer survival patients based on adhesion and proliferation of tumor cells
by: O. D. Ryabtseva, et al.
Published: (2014) -
Biological features of serous ovarian cancer with regard to the r53 expression and its modulators
by: I. P. Nesina, et al.
Published: (2015) -
Survivin expression in ovarian cancer
by: Liguang, Z., et al.
Published: (2007) -
Biomolecular markers as factors of prognosis of stage 3-4 ovarian cancer
by: A. A. Mikhanovskij, et al.
Published: (2016) -
Ovarian cancer: family cancer syndrome and clinical significance of testing of the mutations in BRCA1 and BRCA2?genes
by: O. V. Paliichuk, et al.
Published: (2016)